Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, August 25, 2023.
This week, the FDA granted a fast-track designation for Nectero Medical’s end-vascular aneurysm stabilization treatment system. Fast Five hosts Sean Whooley and Danielle Kirsh explain how the system works and what executives say about this FDA win.
There’s more AFib news on the horizon, this time from GE Healthcare. The company launched its CardioVisio digital tool for helping to treat AFib. Find out what the system does and the ultimate goal for GE Healthcare.
SPAC mergers are back in the news as Sanuwave Health plans to go public after a business combination agreement with SEP Acquisition Corp. The proposed transaction is valued at $127.5 million. Hear more about the financial details of the deal and the optimism that executives have.
Long-term organ preservation is important for organ transplants. Paragonix’s next-generation BAROguard donor lung preservation system won FDA clearance this week. Whooley explains how the system works and what differentiates it from gold-standard organ transportation methods.
Yesterday, we had news about ReCor Medical’s renal denervation system getting positive votes from an FDA review panel. Today, we’re talking about Medtronic’s results, in which the panel said the risks of using the system outweigh the benefits. The Fast Five hosts explain what this means for Medtronic.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
